Patents by Inventor Malcolm Richard Boyd

Malcolm Richard Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
    Publication number: 20100323952
    Abstract: A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Inventor: Malcolm Richard Boyd
  • Nucleoside analogs in combination therapy of herpes simplex infections
    Publication number: 20080287389
    Abstract: A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
    Type: Application
    Filed: July 2, 2008
    Publication date: November 20, 2008
    Inventor: Malcolm Richard Boyd
  • Nucleoside analogs in combination therapy of herpes simplex infections
    Publication number: 20040185433
    Abstract: A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
    Type: Application
    Filed: June 19, 2001
    Publication date: September 23, 2004
    Inventor: Malcolm Richard Boyd
  • Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
    Patent number: 6683084
    Abstract: The use of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing for use in the prophylactic treatment of HHV-6 infection.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: January 27, 2004
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventors: Richard Anthony Vere Hodge, Malcolm Richard Boyd
  • Nucleoside analogs in combination therapy of herpes simplex infections
    Patent number: 6514980
    Abstract: A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: February 4, 2003
    Assignee: Novartis International Pharmaceutical Ltd.
    Inventor: Malcolm Richard Boyd
  • Pharmaceutical treatment
    Patent number: 6136813
    Abstract: Pharmaceutical use of a compound of formula (A): ##STR1## or a pro-drug, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing; in the treatment of hepatitis B virus infections.
    Type: Grant
    Filed: August 8, 1994
    Date of Patent: October 24, 2000
    Assignee: Beecham plc
    Inventors: Malcolm Richard Boyd, David Sutton
  • Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
    Patent number: 6057327
    Abstract: The use of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of HHV-6 infection.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: May 2, 2000
    Assignee: SmithKline Beecham plc
    Inventors: Richard Anthony Vere Hodge, Malcolm Richard Boyd